Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Cheli

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Frontiers in Pediatrics|August 13, 2019
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug ExposureSilvia Corti, Paola Pileri, Martina I Mazzocco, et al.
Journal of Clinical Pharmacy and Therapeutics|November 2, 2016
The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case reportStefania Antoniazzi, Alessandro Tatulli, Felicia S Falvella, et al.
BMC Biology|July 18, 2009
Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiationBeatrice Bodega, Gabriella Di Capua Ramirez, Florian Grasser, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2015
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevirLaura Milazzo, Anna Maria Peri, Cristina Mazzali, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 19, 2024
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medicationGiovanni Maconi, Federica Lepore, Adam Saleh, et al.
Palliative Medicine|May 31, 2026
Fever in a palliative care setting: Clinical insights and implications from a prospective observational cohort studyStefania Cheli, Elena Angeli, Oscar Corli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2024
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control StudyStefania Cheli, Alessandro Torre, Marco Schiuma, et al.
SAGE Open Medicine|June 15, 2018
Clinical and genetic determinants of nevirapine plasma trough concentrationAndrea Giacomelli, Stefano Rusconi, Felicia Stefania Falvella, et al.
The Pharmacogenomics Journal|March 2, 2021
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patientsSara Demurtas, Nicla La Verde, Selene Rota, et al.
BMC Infectious Diseases|November 14, 2018
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapyAndrea Giacomelli, Agostino Riva, Felicia Stefania Falvella, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Pediatrics|August 13, 2019
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug ExposureSilvia Corti, Paola Pileri, Martina I Mazzocco, et al.
Journal of Clinical Pharmacy and Therapeutics|November 2, 2016
The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case reportStefania Antoniazzi, Alessandro Tatulli, Felicia S Falvella, et al.
BMC Biology|July 18, 2009
Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiationBeatrice Bodega, Gabriella Di Capua Ramirez, Florian Grasser, et al.
The Journal of Antimicrobial Chemotherapy|January 14, 2015
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevirLaura Milazzo, Anna Maria Peri, Cristina Mazzali, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 19, 2024
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medicationGiovanni Maconi, Federica Lepore, Adam Saleh, et al.
Palliative Medicine|May 31, 2026
Fever in a palliative care setting: Clinical insights and implications from a prospective observational cohort studyStefania Cheli, Elena Angeli, Oscar Corli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2024
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control StudyStefania Cheli, Alessandro Torre, Marco Schiuma, et al.
SAGE Open Medicine|June 15, 2018
Clinical and genetic determinants of nevirapine plasma trough concentrationAndrea Giacomelli, Stefano Rusconi, Felicia Stefania Falvella, et al.
The Pharmacogenomics Journal|March 2, 2021
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patientsSara Demurtas, Nicla La Verde, Selene Rota, et al.
BMC Infectious Diseases|November 14, 2018
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapyAndrea Giacomelli, Agostino Riva, Felicia Stefania Falvella, et al.
Pageof 5